Please help me...
Posted: Thu Jun 09, 2022 11:22 am
Please help me...
2. (Prof. YS Kim) Clinical Proteomics: From Mass Spectrometry to Diagnostic Platform A. Compare and contrast genomics vs. proteomics in clinical area. B. Explain the workflow for development of proteome-based multi-marker panel for cancer, which is composed of discovery, verification and validation. C. What is HER2+ breast cancer and trastuzumab (Herceptin) targeted therapy? +
2. (Prof. YS Kim) Clinical Proteomics: From Mass Spectrometry to Diagnostic Platform A. Compare and contrast genomics vs. proteomics in clinical area. B. Explain the workflow for development of proteome-based multi-marker panel for cancer, which is composed of discovery, verification and validation. C. What is HER2+ breast cancer and trastuzumab (Herceptin) targeted therapy? +